Thomas N. Sato
Thomas N. Sato is a prominent Japanese educator and biologist, whose research focuses on understanding molecular basis of cancer, cardiac disease and metabolic diseases by using a number of animal models including mice, zebrafish and fruit flies. He is also working to invent next-generation therapeutics for human diseases based on the stochastic basis of life and disease. He is currently professor of biology at the Nara Institute of Science and Technology, Japan, professor at Cornell University, United States and Centenary Institute in Sydney, Australia.[1][2]
Life
- University of Tsukuba, Japan, BS 1985
- Georgetown University, Graduate School of Biological Sciences/Neuroscience, Ph.D. 1988
- Scripps Research Institute, Postdoctoral Fellow 1989-1990
- Roche Institute of Molecular Biology, Assistant Member 1991-1995
- Harvard Medical School, Assistant Professor 1995-1997
- Univ. of Texas Southwestern Medical School, Associate Professor 1997-2001 (Tenured in 1999)
- Univ. of Texas Southwestern Medical School, Professor 2002-2004
- Weill Medical College of Cornell University, Professor 2005-2006
- Weill Medical College of Cornell University, Joseph C. Hinsey Professor 2005-2009
- Nara Institute of Science and TechnologyGraduate School of Biological Sciences, Japan, Professor 2009–present
- Cornell University, Biomedical Engineering, Adjunct Professor 2009–present
- Centenary Institute, Sydney, Australia, Affiliate Professor 2009–present
Works
- Discoveries of Tie1, Tie2, and angiopoietins, that play the key roles in the blood vessel formation.[3][4][5]
References
- ↑ "Laboratory of Biodynamics and Integrative Biology". Archived from the original on 2013-07-05. Retrieved 2013-07-23.
- ↑ "NAIST-Biological Science, Biodynamics and Integrative Biology". Archived from the original on 2013-07-23. Retrieved 2013-07-23.
- ↑ Sato TN, et al. (October 1993). "Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system". Proc. Natl. Acad. Sci. USA. 90 (20): 9355–9358. doi:10.1073/pnas.90.20.9355. PMC 47566. PMID 8415706.
- ↑ Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (Dec 1996). "Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis". Cell. 87 (7): 1171–1180. doi:10.1016/S0092-8674(00)81813-9. PMID 8980224.
- ↑ Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (July 1997). "Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis". Science. 277 (5322): 55–60. doi:10.1126/science.277.5322.55. PMID 9204896.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.